Track CDLR and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
CDLR (CDLR) has a free cash flow of -$528.07M, down 64.7% over the past year and down 98.2% per year over the past five years.
FCF TTM
-$528.07M
FCF Margin
-68.39%
FCF Yield
-26.25%
5Y CAGR
-98.24%
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$980.59M | -64.69% |
| 2024 | -$595.42M | -5591.80% |
| 2023 | $10.84M | +103.21% |
| 2022 | -$337.94M | -44.16% |
| 2021 | -$234.42M | +49.53% |
| 2020 | -$464.50M | -4913.34% |
| 2019 | -$9.27M | - |
| Quarter | Free Cash Flow | Change |
|---|---|---|
| Q1 2026 | -$55.75M | +77.26% |
| Q4 2025 | -$245.11M | -387.81% |
| Q3 2025 | -$50.25M | +71.61% |
| Q2 2025 | -$176.96M | +65.18% |
| Q1 2025 | -$508.27M | -2331.61% |
| Q4 2024 | -$20.90M | +91.87% |
| Q3 2024 | -$256.95M | -18.67% |
| Q2 2024 | -$216.52M | -114.29% |
| Q1 2024 | -$101.04M | -621.64% |
| Q4 2023 | -$14.00M | -151.47% |
| Q3 2023 | $27.20M | +1948.69% |
| Q2 2023 | $1.33M | +136.02% |
| Q1 2023 | -$3.69M | +97.09% |
| Q4 2022 | -$126.86M | -107.38% |
| Q3 2022 | -$61.17M | +38.65% |
| Q2 2022 | -$99.72M | -98.71% |
| Q1 2022 | -$50.18M | +69.23% |
| Q4 2021 | -$163.07M | -106.42% |
| Q3 2021 | -$79.00M | -1963.77% |
| Q2 2021 | $4.24M | +23.99% |
| Q1 2021 | $3.42M | +101.12% |
| Q4 2020 | -$305.90M | -105.35% |
| Q3 2020 | -$148.97M | -1944.64% |
| Q2 2020 | -$7.29M | -211.25% |
| Q1 2020 | -$2.34M | +81.81% |
| Q4 2019 | -$12.87M | -154.86% |
| Q3 2019 | -$5.05M | -205.47% |
| Q2 2019 | $4.79M | +23.78% |
| Q1 2019 | $3.87M | - |
Free cash flow (FCF) is the cash left after a company covers its operating expenses and capital expenditures. It is the money available to repay debt, buy back shares, pay dividends, or reinvest — making it one of the clearest measures of financial strength.